Precigen (PGEN) Gross Margin Growth (5y) (2018 - 2026)
Powered by 
Analysis
Precigen (PGEN) Gross Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.82 Bn | 1.82 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,886.00 |
| Mar 31, 2026 | 1,919.00 |
| Dec 31, 2025 | -11,851.00 |
| Sep 30, 2025 | -448.00 |
| Jun 30, 2025 | -10,081.00 |
| Mar 31, 2025 | -5,677.00 |
| Dec 31, 2024 | -5,236.00 |
| Sep 30, 2024 | -6,267.00 |
| Jun 30, 2024 | -11,553.00 |
| Mar 31, 2024 | -6,675.00 |
| Dec 31, 2023 | -9,349.00 |
| Sep 30, 2023 | -8,192.00 |
| Jun 30, 2023 | -7,116.00 |
| Mar 31, 2023 | -5,954.00 |
| Dec 31, 2022 | -6,138.00 |
| Sep 30, 2022 | 796.00 |
| Jun 30, 2022 | -4,593.00 |
| Mar 31, 2022 | -1,389.00 |
| Dec 31, 2021 | -6,046.00 |
| Sep 30, 2021 | -1,041.00 |